Pharmaceuticals company SMS Pharmaceuticals announced Q3FY26 results Revenue: Rs 21,044.7 lakh against Rs 17,335.33 lakh during Q3FY25, change 21%. PBT: Rs 3,116.01 lakh against Rs 2,243.88 lakh during Q3FY25, change 39%. PAT: Rs 2,318.95 lakh against Rs 1,707.91 lakh during Q3FY25, change 36%. EPS: Rs 2.59 for Q3FY26. Result PDF